Literature DB >> 18989938

A mechanistic study on the phototoxicity of atorvastatin: singlet oxygen generation by a phenanthrene-like photoproduct.

Sara Montanaro1, Virginie Lhiaubet-Vallet, MariaRosaria Iesce Iesce, Lucio Previtera, Miguel Angel Miranda.   

Abstract

Atorvastatin calcium (ATV) is one of the most frequently prescribed drugs worldwide. Among the adverse effects observed for this lipid-lowering agent, clinical cases of cutaneous adverse reactions have been reported and associated with photosensitivity disorders. Previous work dealing with ATV photochemistry has shown that exposure to natural sunlight in aqueous solution leads to photoproducts resulting from oxidation of the pyrrole ring and from cyclization to a phenanthrene derivative. Laser flash photolysis of ATV, at both 266 and 308 nm, led to a transient spectrum with two maxima at lambda= 360 and lambda= 580 nm (tau= 41 micro), which was assigned to the primary intermediate of the stilbene-like photocyclization. On the basis of the absence of a triplet-triplet absorption, the role of the parent drug as singlet oxygen photosensitizer can be discarded. By contrast, a stable phenanthrene-like photoproduct would be a good candidate to play this role. Laser flash photolysis of this compound showed a triplet-triplet transient absorption at lambdamax = 460 nm with a lifetime of 26 micro, which was efficiently quenched by oxygen (kq = 3 (+/-0.2) x 10(9) M(-1) s(-1)). Its potential to photosensitize formation of singlet oxygen was confirmed by spin trapping experiments, through conversion of TEMP to the stable free radical TEMPO. The photoreactivity of the phenanthrene-like photoproduct was investigated using Trp as a marker. The disappearance of the amino acid fluorescence (lambdamax = 340 nm) after increasing irradiation times at 355 nm was taken as a measurement of photodynamic oxidation. To confirm the involvement of a type II mechanism, the same experiment was also performed in D2O; this resulted in a significant enhancement of the reaction rate. On the basis of the obtained photophysical and photochemical results, the phototoxicity of atorvastatin can be attributed to singlet oxygen formation with the phenanthrene-like photoproduct as a photosensitizer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18989938     DOI: 10.1021/tx800294z

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  6 in total

1.  A case of psoriasis worsened by atorvastatin.

Authors:  Emanuele Cozzani; Manuela Scaparro; Aurora Parodi
Journal:  J Dermatol Case Rep       Date:  2009-12-30

2.  Effective atherosclerotic plaque inflammation inhibition with targeted drug delivery by hyaluronan conjugated atorvastatin nanoparticles.

Authors:  Seyedmehdi Hossaini Nasr; Zahra Rashidijahanabad; Sherif Ramadan; Nate Kauffman; Narayanan Parameswaran; Kurt R Zinn; Chunqi Qian; Ripla Arora; Dalen Agnew; Xuefei Huang
Journal:  Nanoscale       Date:  2020-05-07       Impact factor: 7.790

3.  Photoprotective Effects of Selected Amino Acids on Naproxen Photodegradation in Aqueous Media.

Authors:  Kohei Kawabata; Momoka Kanoh; Mayu Okazaki; Rina Maeda; Satomi Mori; Shiori Akimoto; Masanori Inagaki; Hiroyuki Nishi
Journal:  Pharmaceuticals (Basel)       Date:  2020-06-26

4.  The effect of statins on psoriasis severity: a meta-analysis of randomized clinical trials.

Authors:  Mateusz Socha; Aldona Pietrzak; Ewelina Grywalska; Daniel Pietrzak; Dariusz Matosiuk; Paweł Kiciński; Jacek Rolinski
Journal:  Arch Med Sci       Date:  2019-12-06       Impact factor: 3.318

5.  Protein Binding of Lapatinib and Its N- and O-Dealkylated Metabolites Interrogated by Fluorescence, Ultrafast Spectroscopy and Molecular Dynamics Simulations.

Authors:  Inmaculada Andreu; Emilio Lence; Concepción González-Bello; Cristobalina Mayorga; M Consuelo Cuquerella; Ignacio Vayá; Miguel A Miranda
Journal:  Front Pharmacol       Date:  2020-10-30       Impact factor: 5.810

6.  Spectroscopic studies on photodegradation of atorvastatin calcium.

Authors:  Madalina Oprica; Miruna Iota; Monica Daescu; Szilard N Fejer; Catalin Negrila; Mihaela Baibarac
Journal:  Sci Rep       Date:  2021-07-28       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.